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Abstract
Hemoglobin Karachi is a new a chain Variant with amino acid substitution a 5 (A3) Ala-“ Pro. The
hematological data on the propositus were normal. In cellulose acetateelectro phoresis this hemoglobin
migrated towards the anode slower than HbA.
It is the first a-chain abnormal hemoglobin reported from Pakistani population (JPMA 36:206, 1986).
INTRODUCTION
Numerous structural abnormalities of the globin chains have been reported since Pauling et al.1
discovered the first abnormal hemoglobin, sickle cell hemoglobin. Amino acid sequencing later
revealed it to contain a substitution of valine for glutamic acid in the 6th position of the B chain.2
Extensive researches for abnormal hemoglobin’s in many parts of the world have brought to light over
450 structurally altered hemoglobins. They include HbJ Toronto characterized by replacement of an
alanine by aspartic acid in position 5 of the a chain3; Hb Sawara4 Hb Ferndown,5 Hb Dunn,6 Hb
Woodville,7 and Hb Swan river8 in which aspartic acid in position of a chain is replaced by Ala, Val,
Asn, Tyr and Gly respectively. These abnormalities are all present in the helical region A of the a chain.
An abnormal hemoglobin of the same helical region was discovered incidentally in a 24 year old
healthy male who was used as a control during a study on abnormal hemoglobins. In his case, alanine is
replaced by proline in position 5 i.e. helical region A 3. This new variant has been designated Hb
(Karachi).
MATERIALS AND METHODS
Blood samples from the propositus, his mother and two sisters were collected in EDTA and standard
hematological studies were carried out. Hemolysates were prepared by the toluene method9 and globin
was separated according to. Anson and Mirsky’s procedure.10 The electrophoresis of the hemoglobin
was carried out on cellulose acetate membranes (Cela gram II, 78 x 150 mm), in Tris-EDTA- borate
buffer pH 8.4for 30 min at 350 volts11 followed by staining with Amido black lOB12 and Ponceau.13
The globin chains were separated on a CM-Cellulose column (13 x 1 cm) with buffer containing 8M
Urea, 0.05M 2-mercaptoethanol and Na2 HPO4 pH 6.5 to 7.2.14 The peaks separated were checked for
homogeneity by electrophoresis on polyacrylamide gels in Triton x-100.15
The separated a chain was digested with trypsin (Worthington Tos Phe CH2CI treated) at room
temperature, pH 8.5; after 3 hrs the reaction was stopped by addition of 0.5 M HCI.
The tryptic peptides were separated by high voltage electrophoresis (Pherograph, Hamburg, West
Germany) in 0.02M pyridine acetate buffer pH 4.7 for 2 hrs at 2000 volts and chromatography
(Butanol: acetic acid: water: pyridine, 15:3:12:10) to prepare two dimensional peptide maps
(fingerprint.16,17)The peptides were visualized by stronsium ninhydrin spray.18

Amino acid analysis of a chain was carried out on an automatic amino acid analyser (Biotronik GmbH
Munich, West Germany).
The amino acid sequence of the a chain were determined by automatic Edman degradation19 in a
Beckman sequencer 890C (Palo Alto California) by using Quadrol programme (Quadrol concentration
0.25M) and manual sequencing by DABITC method. 20,21
RESULTS
Hematological examination on the propositus revealed the following: Hemoglobin 15.2g/dl; red cell
count 5.lxl012 /1; reticulocytes 0.5%; PCV 47%; MCV 92fl; MCH 30 pg; MCHC 32%; total biirubin
13 u mol/1; serum iron 106 mcg/dl; TIBC 380 mcg/dl. Erythrocyte morphology was normal. Incubation
of fresh red cells with brilliant cresyl blue disclosed no inclusion bodies within the cells. The osmotic
fragility test revealed 50% hemolysis at 0.43% NaC1, being within normal range. A heat stability test22
gave normal results.
The electrophoretic pattern of Hb (Karachi) on cellulose acetate membrane at pH 8.4 is shown in
Figure 1.

It is slower than HbA. Neither the mother nor the two sisters of the propositus showed any abnonnal

bands in electrophoresis of their hemoglobin.
Chromatography of Hb (Karachi) on CM-Cellulose revealed 3 peaks (Fig.2).

The first peak contained unbound material followed by the B and a chain. There was no other peak
detected. The amino and composition of c chain was found to be normal whereas slight elevation of
praline was nosed in a chain.
The fingerprinting of a chain showed a change in its position of peptide 1 (Fig 3).

The amino acid sequence of the whole a chain (upto 30 steps) on sequencer and on manual sequencing
(10 steps) showed a replacement at position 5 of Ala by Pro. There was no trace of Ala in this position
suggesting that the hemoglobin has a2 K B2 and the individual carrying a homozygous variant.
Hb (Karachi) a chain Val Leu Ser Pro Pro Asp
LYs Thr Asn Val
Hb A a chain
val Leu Ser Pro ALa Asp

LYs Thr Asn Val

DISCUSSION
The hematological data showed all values to be in the normal range. The structural studies of the a
chain show that alanine residue at 5th position of the a chain is substituted by a proline residue. Alanine
is ambivalent i.e. neither so hydrophobic that it always point internally in the hemoglobin molecule nor
so hydrophiic as to point externally. Alanine in the 5th position of the a chain, corresponding to the 3rd
residue of the A helix is oriented towards the surface of molecule. Its substitution by proline which has
the same ambivalent characteristics may not produce any change in structure-function relationship. The
a carbon of the side chain of proline loops back to make a second connection to its amine nitrogen,
producing a bend in the main polypeptide chain. This is in apposition to the A 2 proline residue in the
normal hemoglobin. The only other mutation in the helix A 3 position reported is in HbJ Toronto, in
which alarline is replaced by strongly hydrophilic aspartic acid. At helix A4 position as many as 5
mutations are known. This position is involved in the salt bridge with a 127 (HlO) lys and substitutions
in this position resulted in higher oxygen affinity but the Bohr effect and cooperativity were
comparable to HbA.5 The position A3 is not involved in the function of the molecule; as such changes
with ambivalent and hydrophiic amino acids may not affect the physiological functions of the
molecule.
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